Skip to main content
. Author manuscript; available in PMC: 2014 Oct 20.
Published in final edited form as: Hepatology. 2010 Apr;51(4):1168–1175. doi: 10.1002/hep.23477

Table 5. Logistic Regression Analysis of the Association of KIR2DL3-C1 with the Outcome of Interferon Treatment.

95% CI
P OR Lower Upper
Age <40 .001 4.44 1.85 10.64
Pegylated IFN + Ribavirin .003 7.66 1.98 29.67
Genotype 1 .021 0.18 0.04 0.77
KIR2DL3-C1 .028 2.34 1.01 5.00
Normal ALT .063 1.95 0.97 3.93
Race .218 0.38 0.08 1.76
Dose reduction .323 0.64 0.26 1.56
Cirrhosis .514 0.64 0.17 2.46
Duration 24 versus 48 .663 0.99 0.92 1.05
Sex .935 1.03 0.50 2.13